US 2013/0096115 A1Published application

Methods for treating autism

AssigneeAfraxis, Inc.

InventorsJay Lichter, David Campbell, Benedikt Vollrath, Sergio G. Durón

Life of this patent

Estimating the term…

Abstract

Provided herein are PAK inhibitors. Also provided herein are compositions and methods for treating an individual suffering from autism.

Claims21

Dependent claims

A method for treating autism comprising administering to an individual in need thereof a therapeutically effective amount of a p21-activated kinase (PAK) inhibitor.

Dependencies are inferred from the claim text.

Facts

Application: 13/519,299Filed 21 Dec 2010
Priority: 28 Dec 2009
Published: 18 Apr 2013
Term ends: Not estimatedThe source records don’t support an estimate.

Classification13 codes

C07D 471/04
In which the condensed system contains two hetero rings: ortho-condensed systems
A61K 31/496
Having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines: non-condensed piperazines…
A61K 31/519
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim: ortho- or peri-condensed with heterocyclic rings
A61K 31/5377
1,4-Oxazines, e.g. morpholine: not condensed and containing further heterocyclic rings, e.g. timolol

Family

Application61/290,480Us provisional application · filed 28 Dec 2009
US 2013/0096115 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results